Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance (Review)

Approximately 15-20% of breast carcinomas exhibit human epidermal growth factor receptor (HER2) protein overexpression. HER2-positive breast cancer (BC) is a heterogeneous and aggressive subtype with poor prognosis and high relapse risk. Although several anti-HER2 drugs have achieved substantial eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Linfei, Han, Fang, Zhu, Liang, Ding, Wenli, Zhang, Kexin, Kan, Chengxia, Hou, Ningning, Li, Qinying, Sun, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990588/
https://www.ncbi.nlm.nih.gov/pubmed/36866766
http://dx.doi.org/10.3892/ijo.2023.5496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990588/
https://www.ncbi.nlm.nih.gov/pubmed/36866766
http://dx.doi.org/10.3892/ijo.2023.5496

Ejemplares similares